Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
- PMID: 12707287
- DOI: 10.1161/01.HYP.0000069700.62727.C5
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
Abstract
Hyperuricemia is associated with hypertension, vascular disease, renal disease, and cardiovascular events. In this report, we review the epidemiologic evidence and potential mechanisms for this association. We also summarize experimental studies that demonstrate that uric acid is not inert but may have both beneficial functions (acting as an antioxidant) as well as detrimental actions (to stimulate vascular smooth muscle cell proliferation and induce endothelial dysfunction). A recently developed experimental model of mild hyperuricemia also provides the first provocative evidence that uric acid may have a pathogenic role in the development of hypertension, vascular disease, and renal disease. Thus, it is time to reevaluate the role of uric acid as a risk factor for cardiovascular disease and hypertension and to design human studies to address this controversy.
Similar articles
-
The role of hyperuricemia and gout in kidney and cardiovascular disease.Cleve Clin J Med. 2008 Jul;75 Suppl 5:S13-6. doi: 10.3949/ccjm.75.suppl_5.s13. Cleve Clin J Med. 2008. PMID: 18822470 Review.
-
Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.Nephrology (Carlton). 2004 Dec;9(6):394-9. doi: 10.1111/j.1440-1797.2004.00336.x. Nephrology (Carlton). 2004. PMID: 15663643 Review.
-
Uric acid as a cardiometabolic risk factor: to be or not to be.Contrib Nephrol. 2011;171:62-67. doi: 10.1159/000327160. Epub 2011 May 23. Contrib Nephrol. 2011. PMID: 21625091 Review.
-
Hyperuricemia, urate deposition and the association with hypertension.Curr Med Res Opin. 2015;31 Suppl 2:15-9. doi: 10.1185/03007995.2015.1087981. Curr Med Res Opin. 2015. PMID: 26414732 Review.
-
Uric acid and cardiovascular risk.N Engl J Med. 2008 Oct 23;359(17):1811-21. doi: 10.1056/NEJMra0800885. N Engl J Med. 2008. PMID: 18946066 Free PMC article. Review. No abstract available.
Cited by
-
Assessing brain microstructural changes in chronic kidney disease: a diffusion imaging study using multiple models.Front Neurol. 2024 May 1;15:1387021. doi: 10.3389/fneur.2024.1387021. eCollection 2024. Front Neurol. 2024. PMID: 38751882 Free PMC article.
-
Non-Interventional Weight Changes Are Associated with Alterations in Serum Uric Acid Levels.J Clin Med. 2024 Apr 17;13(8):2314. doi: 10.3390/jcm13082314. J Clin Med. 2024. PMID: 38673586 Free PMC article.
-
Associations between hyperuricemia and ultrasound-detected knee synovial abnormalities in middle-aged and older population: a cross-sectional study.J Orthop Surg Res. 2024 Apr 4;19(1):226. doi: 10.1186/s13018-024-04708-w. J Orthop Surg Res. 2024. PMID: 38575963 Free PMC article.
-
Cardiovascular safety of febuxostat versus allopurinol among the Asian patients with or without gout: A systematic review and meta-analysis.Clin Transl Sci. 2024 Mar;17(3):e13757. doi: 10.1111/cts.13757. Clin Transl Sci. 2024. PMID: 38488426 Free PMC article.
-
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.Cells. 2024 Mar 4;13(5):450. doi: 10.3390/cells13050450. Cells. 2024. PMID: 38474414 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical